Korsana Biosciences, Inc. (KRSA) vs Maze Therapeutics, Inc. (MAZE)

Korsana Biosciences, Inc. and Maze Therapeutics, Inc. are both Biotechnology companies. Korsana Biosciences, Inc. and Maze Therapeutics, Inc. are of similar size ($1.5B and $1.5B). Across the 10 metrics below, Maze Therapeutics, Inc. leads on 7 and Korsana Biosciences, Inc. on 3.

Valuation

Metric KRSA MAZE Biotechnology median
P/E n/m n/m 8.50
P/S 9.48 n/m 9.71
P/B 3.87 3.58 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 8.81 n/m 9.21
Earnings yield (35.88%) (9.15%) (33.15%)
Free cash flow yield (23.00%) (6.58%) (25.50%)

Profitability

Metric KRSA MAZE Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (98.22%) (37.35%) (56.36%)
Return on assets (82.29%) (31.99%) (48.04%)
Return on invested capital (115.40%) (112.36%) 0.00%

Growth

Metric KRSA MAZE Biotechnology median
Revenue growth (TTM) 30.77% — 6.02%
EPS growth (last fiscal year) 8.26% (344.00%) 30.26%
Revenue growth, 5-year CAGR (14.38%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric KRSA MAZE Biotechnology median
Debt to equity 0.00 0.09 0.00
Current ratio 0.82 18.31 4.72
Net debt to EBITDA 0.65 2.43 0.96

Dividend

Metric KRSA MAZE Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KRSA MAZE Biotechnology median
Market cap 1.53b 1.53b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack